2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 Wiley 2026暑期线上学习营 | 报名正式开启！ | 热 多本ABS四星！优质经管国际期刊列表 | 热 全流程投稿协助套餐服务 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | MEDICAL ONCOLOGY MED ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 6.2
63人评分
我要评分
声誉 7.3 影响力 5.3 速度 6.6 | |||||||||||||||||||||||||
| 期刊ISSN | 1357-0560 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||
| E-ISSN | 1559-131X | |||||||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：4.64 | |||||||||||||||||||||||||
| 2025-2026自引率 | 4.3%点击查看自引率趋势图 | |||||||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 3.995数据由网友[冰淇淋7674]收集提供 | |||||||||||||||||||||||||
| h-index | 64 | |||||||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||
| 期刊官方网站 | https://www.springer.com/12032 | |||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/medo/ | |||||||||||||||||||||||||
| 作者指南网址 | https://www.springer.com/12032/submission-guidelines | |||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Lactate and lactylation in hepatocellular carcinoma: A new frontier in metabolic-epigenetic interactions Author: Chen, Chen; Miao, Yangyang; Fan, Songsong; Tang, Chengji; Peng, Rui; Zhang, Jiahao; Cao, Jun; Zhang, Chi; Bai, Dousheng Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 7, pp. -. DOI: 10.1007/s12032-026-03323-5 LncRNA LOXL1-AS1 promotes ovarian cancer progression by enhanced BRIP1 mRNA stability (vol 42, 504, 2025) Author: Wan, Su; Su, Chang; Ding, Jin; Liu, Ji; He, Lingli; Liu, Lifen; Peng, Qi; Ni, Guantai; Zhu, Weipei Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 7, pp. -. DOI: 10.1007/s12032-026-03289-4 Exploration of the mechanism by which Ubiquitin-like protein UBD promotes malignant progression of breast cancer Author: Ma, Lei; Xie, Bei; Zhang, Rongzhi; Deng, Haohua; Tang, Baoyuan; Zhu, Jinmei; Zhang, Ziqing; Ma, Xingyuan; Wang, Shuaiyang; Li, Linjing Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 6, pp. -. DOI: 10.1007/s12032-025-03168-4 Diosmetin overcomes resistance to cisplatin in ovarian cancer by suppressing the MAPK signaling pathway Author: Nie, Juan; Jiang, Hequn; Zhou, Runyu; Gong, Ruichen; Xu, Wenli; Zhang, Ping; Lu, Ling; Lyu, Lin Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 5, pp. -. DOI: 10.1007/s12032-026-03293-8 | |||||||||||||||||||||||||
| 期刊语言要求 | Language Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足MEDICAL ONCOLOGY的语言要求，还能让MEDICAL ONCOLOGY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被MEDICAL ONCOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||
| 通讯方式 | HUMANA PRESS INC, 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, USA, NJ, 07512 | |||||||||||||||||||||||||
| 出版商 | Springer US | |||||||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||
| 出版周期 | Quarterly | |||||||||||||||||||||||||
| 出版年份 | 1984 | |||||||||||||||||||||||||
| 年文章数 | 596点击查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 14.25% | |||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 52.68% | |||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||
  | ||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1357-0560%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均1.4月 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约63.33% | |||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在MEDICAL ONCOLOGY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Lactate and lactylation in hepatocellular carcinoma: A new frontier in metabolic-epigenetic interactions Author: Chen, Chen; Miao, Yangyang; Fan, Songsong; Tang, Chengji; Peng, Rui; Zhang, Jiahao; Cao, Jun; Zhang, Chi; Bai, Dousheng Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 7, pp. -. DOI: 10.1007/s12032-026-03323-5 PubMed DOI |
| 2. | LncRNA LOXL1-AS1 promotes ovarian cancer progression by enhanced BRIP1 mRNA stability (vol 42, 504, 2025) Author: Wan, Su; Su, Chang; Ding, Jin; Liu, Ji; He, Lingli; Liu, Lifen; Peng, Qi; Ni, Guantai; Zhu, Weipei Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 7, pp. -. DOI: 10.1007/s12032-026-03289-4 PubMed DOI |
| 3. | Exploration of the mechanism by which Ubiquitin-like protein UBD promotes malignant progression of breast cancer Author: Ma, Lei; Xie, Bei; Zhang, Rongzhi; Deng, Haohua; Tang, Baoyuan; Zhu, Jinmei; Zhang, Ziqing; Ma, Xingyuan; Wang, Shuaiyang; Li, Linjing Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 6, pp. -. DOI: 10.1007/s12032-025-03168-4 PubMed DOI |
| 4. | Diosmetin overcomes resistance to cisplatin in ovarian cancer by suppressing the MAPK signaling pathway Author: Nie, Juan; Jiang, Hequn; Zhou, Runyu; Gong, Ruichen; Xu, Wenli; Zhang, Ping; Lu, Ling; Lyu, Lin Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 5, pp. -. DOI: 10.1007/s12032-026-03293-8 PubMed DOI |
| 5. | RETRACTION: The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer Author: He, Tian-Lin; Zhang, Yi-Jie; Jiang, Hui; Li, Xiao-hui; Zhu, Hai; Zheng, Kai-Lian Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 5, pp. -. DOI: 10.1007/s12032-026-03296-5 PubMed DOI |
| 6. | A novel matrine derivative exerts antitumor effects against hepatocellular carcinoma by inducing oxidative stress and DNA damage Author: Hu, Zhouxing; Wang, Xingdong; Xu, Tingguo; Ou, Anqi; Song, Yuanbo; Wang, Lisheng Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 4, pp. -. DOI: 10.1007/s12032-026-03243-4 PubMed DOI |
| 7. | Research progress and clinical translation challenges in the use of oncolytic bacteria for cancer therapy Author: Lu, Min; Sun, Zhimin; Qian, Yimin; Guo, Jingxu; Liang, Yaping; Han, Kexin; Yan, Weiyuan; Gao, Yaxin; Wang, Kou; Jiang, Minjie; Liu, Yueling; Yang, Bin; Wang, Yan; Tang, Naping Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 4, pp. -. DOI: 10.1007/s12032-026-03269-8 PubMed DOI |
| 8. | Dysregulated immune microenvironment in metastatic colorectal cancer Author: An, Shuaixing; Yu, Zhaojin; Li, Jianping; Wei, Minjie Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 4, pp. -. DOI: 10.1007/s12032-025-03112-6 PubMed DOI |
| 9. | Elbasvir triggers ferroptosis in esophageal squamous cell carcinoma through NCOA4-mediated ferritinophagy Author: Tang, Maoju; Gong, Feng; Yang, Miyuan; He, Shuang; Cheng, Jiao; Yang, Zhiheng; Xu, Lei; Ma, Qiang; Guo, Xiaolan; Zhong, Xiaowu Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 3, pp. -. DOI: 10.1007/s12032-026-03249-y PubMed DOI |
| 10. | Engineered mesenchymal stem cells expressing CXCR4 and LIGHT enhance Anti-Tumor activity in a subcutaneous gastric cancer xenograft model Author: Anayyat, Umer; Ye, Jianbin; Wu, Xumin; Liu, Zhiyu; Liao, Cui; Wang, Xiaomei; Liu, Muyun Journal: MEDICAL ONCOLOGY. 2026; Vol. 43, Issue 3, pp. -. DOI: 10.1007/s12032-026-03271-0 PubMed DOI |
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共620条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
